In last trading session, Petros Pharmaceuticals Inc (NASDAQ:PTPI) saw 1.53 million shares changing hands with its beta currently measuring 1.93. Company’s recent per share price level of $0.36 trading at -$0.05 or -11.24% at ring of the bell on the day assigns it a market valuation of $3.65M. That closing price of PTPI’s stock is at a discount of -530.56% from its 52-week high price of $2.27 and is indicating a premium of 38.89% from its 52-week low price of $0.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.52 million shares which gives us an average trading volume of 1.94 million if we extend that period to 3-months.

Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information

Upright in the red during last session for losing -11.24%, in the last five days PTPI remained trading in the red while hitting it’s week-highest on Tuesday, 01/07/25 when the stock touched $0.36 price level, adding 44.62% to its value on the day. Petros Pharmaceuticals Inc’s shares saw a change of -7.59% in year-to-date performance and have moved -7.59% in past 5-day. Petros Pharmaceuticals Inc (NASDAQ:PTPI) showed a performance of 8.66% in past 30-days. Number of shares sold short was 0.2 million shares which calculate 0.72 days to cover the short interests.

Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders

Insiders are in possession of 8.10% of company’s total shares while institution are holding 2.29 percent of that, with stock having share float percentage of 2.49%. Investors also watch the number of corporate investors in a company very closely, which is 2.29% institutions for Petros Pharmaceuticals Inc that are currently holding shares of the company.